We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Houlihan Lokey (HLI - Free Report) ) has long been one of the most respected names in independent investment banking, but its stock is now facing a meaningful shift in analyst sentiment.
Over the past several weeks, earnings estimates have been moving sharply lower, with the downward trend reflecting a combination of softer-than-expected financial results, weakening momentum in key business lines, and cautious management commentary.
With EPS revisions falling this broadly, Houlihan’s stock has been flagged as a potential underperformer, landing a Zacks Rank #5 (Strong Sell) and the Bear of the Day.
Image Source: Zacks Investment Research
A Double Miss That Reset Expectations
Sparking concerns was Houlihan’s most recent fiscal fourth-quarter report last month, the catalyst for what has been a wave of downward EPS revisions:
Q4 Revenue of $635.64 million missed the $687.1 million Consensus by 7% and fell 4% from the prior year quarter.
Q4 EPS of $1.63 missed expectations of $1.84 by 11% and dropped from $1.96 a year ago.
Image Source: Zacks Investment Research
A miss on both the top and bottom line is usually enough to trigger estimate cuts, but what concerned analysts even more was that the weakness showed up in Houlihan’s core Financial Restructuring (FR) business, which advises companies, creditors, private equity sponsors, and other stakeholders when a company is under financial stress or needs to reorganize its balance sheet.
Restructuring Slowdown & Broad Underperformance
Best known for its leadership in financial restructuring, a segment that historically delivers some of Houlihan's highest margins, recent declines have raised eyebrows.
To that point, Q4 Restructuring revenue fell 33% YoY to $110.4 million and noticeably missed expectations of $137.2 million.
This is a notable shift because restructuring tends to boom during periods of broader economic uncertainty, which, of course, has been highlighted by elevated interest rates and higher energy prices from the War in Iran. That said, the current restructuring environment has seen fewer large-scale distress situations. With the cycle cooling, analysts are recalibrating their forward assumptions.
Furthermore, the weakness wasn’t isolated to restructuring, as revenue for Houlihan’s Corporate Finance and Valuation Advisory segments also came in below expectations:
Q4 Corporate Finance revenue: $433.8M vs. $448.8M expected
Q4 Valuation Advisory revenue: $91.5M vs. $95.5M expected
When every major business line misses estimates, analysts tend to assume the softness is macro-driven and likely to persist.
Management’s Tone Adds to the Pressure
Even though Houlihan still delivered a record fiscal year, management struck a noticeably cautious tone about the near-term environment, citing “uncertainty” as the firm enters its FY27. When leadership signals hesitation on top of recent quarterly underperformance, analysts usually trim their outlook.
Analysts Respond With EPS Cuts
As shown below, Houlihan’s EPS revisions are starting to decline across the board, highlighted by what is now a 12% drop in Q1 earnings estimates over the last 60 days and a 4% drop in full-year FY27 earnings estimates.
Image Source: Zacks Investment Research
What investors may also want to keep in mind is that while Houlihan stock is trading at a reasonable 17X forward earnings multiple, this is a sharp premium to its Zacks Financial-Miscellaneous Services Industry average of 10X, with other noteworthy peers being American Express (AXP - Free Report) ), Coinbase (COIN - Free Report) ), and LendingClub (LC - Free Report) ).
Image Source: Zacks Investment Research
Bottom Line
Houlihan Lokey remains a high-quality financial investment bank with a strong long-term track record, but the trend of declining EPS revisions suggests short-term weakness is still ahead.
Until analysts see stabilization or a pickup in dealmaking or restructuring activity, Houlihan's stock is likely to remain under pressure after falling nearly 20% in the last six months.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Bear of the Day: Houlihan Lokey (HLI)
Houlihan Lokey (HLI - Free Report) ) has long been one of the most respected names in independent investment banking, but its stock is now facing a meaningful shift in analyst sentiment.
Over the past several weeks, earnings estimates have been moving sharply lower, with the downward trend reflecting a combination of softer-than-expected financial results, weakening momentum in key business lines, and cautious management commentary.
With EPS revisions falling this broadly, Houlihan’s stock has been flagged as a potential underperformer, landing a Zacks Rank #5 (Strong Sell) and the Bear of the Day.
Image Source: Zacks Investment Research
A Double Miss That Reset Expectations
Sparking concerns was Houlihan’s most recent fiscal fourth-quarter report last month, the catalyst for what has been a wave of downward EPS revisions:
Image Source: Zacks Investment Research
A miss on both the top and bottom line is usually enough to trigger estimate cuts, but what concerned analysts even more was that the weakness showed up in Houlihan’s core Financial Restructuring (FR) business, which advises companies, creditors, private equity sponsors, and other stakeholders when a company is under financial stress or needs to reorganize its balance sheet.
Restructuring Slowdown & Broad Underperformance
Best known for its leadership in financial restructuring, a segment that historically delivers some of Houlihan's highest margins, recent declines have raised eyebrows.
To that point, Q4 Restructuring revenue fell 33% YoY to $110.4 million and noticeably missed expectations of $137.2 million.
This is a notable shift because restructuring tends to boom during periods of broader economic uncertainty, which, of course, has been highlighted by elevated interest rates and higher energy prices from the War in Iran. That said, the current restructuring environment has seen fewer large-scale distress situations. With the cycle cooling, analysts are recalibrating their forward assumptions.
Furthermore, the weakness wasn’t isolated to restructuring, as revenue for Houlihan’s Corporate Finance and Valuation Advisory segments also came in below expectations:
When every major business line misses estimates, analysts tend to assume the softness is macro-driven and likely to persist.
Management’s Tone Adds to the Pressure
Even though Houlihan still delivered a record fiscal year, management struck a noticeably cautious tone about the near-term environment, citing “uncertainty” as the firm enters its FY27. When leadership signals hesitation on top of recent quarterly underperformance, analysts usually trim their outlook.
Analysts Respond With EPS Cuts
As shown below, Houlihan’s EPS revisions are starting to decline across the board, highlighted by what is now a 12% drop in Q1 earnings estimates over the last 60 days and a 4% drop in full-year FY27 earnings estimates.
Image Source: Zacks Investment Research
What investors may also want to keep in mind is that while Houlihan stock is trading at a reasonable 17X forward earnings multiple, this is a sharp premium to its Zacks Financial-Miscellaneous Services Industry average of 10X, with other noteworthy peers being American Express (AXP - Free Report) ), Coinbase (COIN - Free Report) ), and LendingClub (LC - Free Report) ).
Image Source: Zacks Investment Research
Bottom Line
Houlihan Lokey remains a high-quality financial investment bank with a strong long-term track record, but the trend of declining EPS revisions suggests short-term weakness is still ahead.
Until analysts see stabilization or a pickup in dealmaking or restructuring activity, Houlihan's stock is likely to remain under pressure after falling nearly 20% in the last six months.